3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
4
Other neoplasm
1
Gastrointestinal
1
Conditions
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
fludarabine
5
Educational Status
5
fludarabine phosphate
4
Whole-Body Irradiation
4
Mycophenolic Acid
4
Methods
4
Melphalan
4
Magnetic Resonance Spectroscopy
4
Early Intervention, Educational
4
Cyclophosphamide
4
Busulfan
4
Biopsy
4
Taxes
3
Tacrolimus
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Interviews as Topic
3
venetoclax
2
Sirolimus
2
Patient Reported Outcome Measures
2
Nivolumab
2
Mesna
2
Health Promotion
2
Colposcopy
2
Cisplatin
2
Aminolevulinic Acid
2
Albumin-Bound Paclitaxel
2
toripalimab
1
tirbanibulin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acetic Acid
×
Other neoplasm
×
1 year
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled